135 related articles for article (PubMed ID: 15537355)
1. AT2-selective angiotensin II analogues containing tyrosine-functionalized 5,5-bicyclic thiazabicycloalkane dipeptide mimetics.
Johannesson P; Erdélyi M; Lindeberg G; Frändberg PA; Nyberg F; Karlén A; Hallberg A
J Med Chem; 2004 Nov; 47(24):6009-19. PubMed ID: 15537355
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II analogues encompassing 5,9- and 5,10-fused thiazabicycloalkane tripeptide mimetics.
Johannesson P; Lindeberg G; Tong W; Gogoll A; Synnergren B; Nyberg F; Karlén A; Hallberg A
J Med Chem; 1999 Nov; 42(22):4524-37. PubMed ID: 10579816
[TBL] [Abstract][Full Text] [Related]
3. Bicyclic tripeptide mimetics with reverse turn inducing properties.
Johannesson P; Lindeberg G; Tong W; Gogoll A; Karlén A; Hallberg A
J Med Chem; 1999 Feb; 42(4):601-8. PubMed ID: 10052967
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity.
Georgsson J; Sköld C; Plouffe B; Lindeberg G; Botros M; Larhed M; Nyberg F; Gallo-Payet N; Gogoll A; Karlén A; Hallberg A
J Med Chem; 2005 Oct; 48(21):6620-31. PubMed ID: 16220978
[TBL] [Abstract][Full Text] [Related]
5. A selective AT2 receptor ligand with a gamma-turn-like mimetic replacing the amino acid residues 4-5 of angiotensin II.
Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Karlén A; Hallberg A
J Med Chem; 2004 Feb; 47(4):859-70. PubMed ID: 14761188
[TBL] [Abstract][Full Text] [Related]
6. New selective AT2 receptor ligands encompassing a gamma-turn mimetic replacing the amino acid residues 4-5 of angiotensin II act as agonists.
Rosenström U; Sköld C; Plouffe B; Beaudry H; Lindeberg G; Botros M; Nyberg F; Wolf G; Karlén A; Gallo-Payet N; Hallberg A
J Med Chem; 2005 Jun; 48(12):4009-24. PubMed ID: 15943474
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and incorporation of a beta-turn mimetic in angiotensin II forming novel pseudopeptides with affinity for AT1 and AT2 receptors.
Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Karlén A; Hallberg A
J Med Chem; 2006 Oct; 49(20):6133-7. PubMed ID: 17004728
[TBL] [Abstract][Full Text] [Related]
8. Conformationally constrained CCK4 analogues incorporating IBTM and BTD beta-turn mimetics.
Martín-Martínez M; De la Figuera N; Latorre M; García-López MT; Cenarruzabeitia E; Del Río J; González-Muñiz R
J Med Chem; 2005 Dec; 48(24):7667-74. PubMed ID: 16302807
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptor.
Georgsson J; Sköld C; Botros M; Lindeberg G; Nyberg F; Karlén A; Hallberg A; Larhed M
J Med Chem; 2007 Apr; 50(7):1711-5. PubMed ID: 17358051
[TBL] [Abstract][Full Text] [Related]
10. Short pseudopeptides containing turn scaffolds with high AT2 receptor affinity.
Georgsson J; Rosenström U; Wallinder C; Beaudry H; Plouffe B; Lindeberg G; Botros M; Nyberg F; Karlén A; Gallo-Payet N; Hallberg A
Bioorg Med Chem; 2006 Sep; 14(17):5963-72. PubMed ID: 16753301
[TBL] [Abstract][Full Text] [Related]
11. Vinyl sulfide cyclized analogues of angiotensin II with high affinity and full agonist activity at the AT(1) receptor.
Johannesson P; Lindeberg G; Johansson A; Nikiforovich GV; Gogoll A; Synnergren B; Le Grèves M; Nyberg F; Karlén A; Hallberg A
J Med Chem; 2002 Apr; 45(9):1767-77. PubMed ID: 11960488
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three gamma-turn mimetic scaffolds incorporated into angiotensin II.
Lindman S; Lindeberg G; Nyberg F; Karlén A; Hallberg A
Bioorg Med Chem; 2000 Sep; 8(9):2375-83. PubMed ID: 11026551
[TBL] [Abstract][Full Text] [Related]
13. Multiple binding modes for the receptor-bound conformations of cyclic AII agonists.
Plucinska K; Kataoka T; Yodo M; Cody WL; He JX; Humblet C; Lu GH; Lunney E; Major TC; Panek RL
J Med Chem; 1993 Jun; 36(13):1902-13. PubMed ID: 8515427
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and AT2 receptor-binding properties of angiotensin II analogues.
Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Hallberg A; Karlén A
J Pept Res; 2004 Nov; 64(5):194-201. PubMed ID: 15485557
[TBL] [Abstract][Full Text] [Related]
15. Modeling binding modes of angiotensin II and pseudopeptide analogues to the AT2 receptor.
Sköld C; Nikiforovich G; Karlén A
J Mol Graph Model; 2008 Feb; 26(6):991-1003. PubMed ID: 17936050
[TBL] [Abstract][Full Text] [Related]
16. Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP).
Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M; Erdélyi M; Hallberg A
J Med Chem; 2010 Nov; 53(22):8059-71. PubMed ID: 21047126
[TBL] [Abstract][Full Text] [Related]
17. A new bicyclic dipeptide isostere with pyrrolizidinone skeleton.
Cordero FM; Pisaneschi F; Meschini Batista K; Valenza S; Machetti F; Brandi A
J Org Chem; 2005 Feb; 70(3):856-67. PubMed ID: 15675843
[TBL] [Abstract][Full Text] [Related]
18. From macrocycle dipeptide lactams to azabicyclo[X.Y.0]alkanone amino acids: a transannular cyclization route for peptide mimic synthesis.
Surprenant S; Lubell WD
Org Lett; 2006 Jun; 8(13):2851-4. PubMed ID: 16774273
[TBL] [Abstract][Full Text] [Related]
19. Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters.
Kolhatkar R; Cook CD; Ghorai SK; Deschamps J; Beardsley PM; Reith ME; Dutta AK
J Med Chem; 2004 Oct; 47(21):5101-13. PubMed ID: 15456254
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, receptor binding affinities and conformational properties of cyclic methylenedithioether analogues of angiotensin II.
Lindman S; Lindeberg G; Gogoll A; Nyberg F; Karlén A; Hallberg A
Bioorg Med Chem; 2001 Mar; 9(3):763-72. PubMed ID: 11310611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
